DebraPatt,MDMPHMBAExecutiveVicePresident,PolicyandStrategicInitiatives,TexasOncology

Dr.DebraPattisanExecutiveVicePresidentofTexasOncology,aclinicalprofessoratDellMedicalSchool,andabreastcancer

specialistinAustin,Texaswhohasacareerresearchfocusinclinicalcancerinformatics.Shehasresponsibilitiesinhealthcarepolicy

andstrategicinitiativesforherstatewidepracticethatcaresforhalfofTexanswithcancer.Inadditiontoherclinicalworkandresearch

leadership,sheisresponsibleforthestrategicgrowthoftheadvancedpracticeproviderprogram,growthoftelemedicine,andassistsin

managedcare,valuebasedcaremodels,oraloncolytics,publicpolicy,andclinicalinformatics.ShehastestifiedbeforeCongressto

protectaccesstocareforMedicarebeneficiariesandadvocatesforcancerpatientsatthehighestlevelsofthestateandfederal

government.SheisaleaderinclinicalcancerinformaticsandservesastheinauguralEditorinChiefofJCO-ClinicalCancerInformatics

andhasledmultipleinnovativeinformaticsandanalyticsinitiativeswithinTheUSOncologyNetworkwheresheservesasthemedical

directorofanalyticsforMcKessonSpecialtyHealthandisworkingwiththeMckessonteamonacentralized2021analyticsstrategy.Her

informaticsresearchincludesleadingthedevelopmentofclinicaldecisionsupportembeddedwithintheelectronichealthrecordand

workstodevelopelectronicpatientreportedoutcomesembeddedwithinpatientsupporttoolswithinpatientportals.Sheistheprincipal

investigatorforpredictiveanalyticstopredictandreducehospitalizationsinpatientswithadvancedcancer,andparticipatesinthe

precisionmedicineworkgrouptofacilitatedecisionsupportwithintheprecisionmedicinestrategy.

PersonalInfo

E-mailpattdebra@yahoo.com

LinkedInlinkedin.com/in/debra-patt-md-mph-

mba-274828b

Twittertwitter.com/dapattmd

IntellectualPropertyDevelopment

Chair,PathwaysTaskForce,MSH

PrincipalInvestigator,UsingClinical

DecisionSupporttoImprove

GuidelinebasedDecisionMaking,

MSH

PrincipalInvestigator,Predictive

AnalyticsPilot,MSH

PortalsAdvisoryBoard,MSH

TechnologyandEHRsWorking

Group,ASCO

Experience

2015-12-present

ExecutiveVicePresidentTexasOncology,PolicyandStrategicInitiatives

Responsibilities:

PublicPolicyGuideanddirectpublicpolicyatStateandFederalLeveltoimprovecancer

care.

TestifiedbeforeCongressE&CagainstMedicarepartBpilotprogram,which

waslaterrescinded.

Meetwithpolicymakersasappropriate.

Managerelationshipstosupportcollaborativebusinessagreements.

Managerelationshipswithexternalstakeholders:ASCO,COA,TMA,AMAto

advocateonbehalfofcommunityoncologypatients.

Manageacademicpartnerships(CoPIonGrantswithDellMedicalSchool

andUniversityofNorthCarolinausingtechnologytoenhancecancercare).

StrategicPrioritiesGrowstrategicPriorities:AdvancedPracticeProviders,Telehealth,Oral

Oncolytics,ManagedCare,Assistinreformulationofphysiciancompensation

modeltoincentivizeproductivity,value,andquality.

DevelopingAdvancedPracticeProviderStrategy

DevelopingTelehealthprogram

Workingwithteamtodevelopandsupportoraloncolyticsstrategy

Workingwithmanagedcareteamtoarticulateourvaluepropositionto

payersanddevelopalternativepaymentmodelcontractstoenhancevalue

basedcancercaredelivery.

Workingwiththeprecisionmedicinegrouptounderstandoptimal

implementationstrategyofincorporationofprecisionmedicineintoour

clinicalworkflow.

2007-present

MedicalDirector,PathwaysTaskForceTheUSOncologyNetworkandMSH

Chairthebreastcancerpathwaysandassistthetaskforceininclusionof

therapeuticinterventionswithconsiderationofefficacy,toxicity,andvalue.

PrincipalinvestigatoronCVPclinicaldecisionsupporttooldemonstrationof

improvedadherencetopathwaysprescribingbyintegratingthesoftware

platformintotheelectronichealthrecordandprocessworkflowatpointof

care.

2015-present

MedicalDirector,AnalyticsMcKessonSpecialtyHealth

Assistteamtointegrateanalyticcapabilitieswithintheorganization.

Workswithteamtoidentifynewareasofgrowth,futureretailmodels,

manufacturervalueproposition,needsofspecialtyprograms,andidentify

operatingmodel.

Facilitatedtransitioningfromprojectdirectedapproachestosustained

enterprisemindsetwithgrowthofdisruptiveindustrysolutions.

Evaluateexternalvendorrelationshipsandverticalintegrationacquisitionsto

consideroptimalgrowthstrategies.

WorkwithMCKandMSHtowardacongruentMcKesson2021analytics

strategy.

Principalinvestigatorforpredictiveanalyticspilotstoimprovehealth

outcomesandreducetotalcostofcare.

2016-present

ServiceLineLead,BreastHealth,DivisionofWomen'sHealthServicesDellMedicalSchoolatTheUniversityofTexasatAustin

Leadclinicalintegrationofbreastservicesleadinguptoacancerdiagnosis

forDellMedicalSchool.

LeadtheNC3committeeandprovideupdatesonbreasthealthservices.

Integratecommunitystakeholdersasitpertainstobreasthealth.

2017-present

FullClinicalProfessorDellMedicalSchoolatTheUniversityofTexasatAustin

TeachMedicalStudentsOncologysectionsofthecurriculum.

Workwithmedicalstudentsonresearchprojectstopresentatannual

meetings.

Co-Principalinvestigator:Decisionsupportinbreastcancer.

Co-PrincipalInvestigator:UseofdynamicMRItoevaluateearlyresponders

inbreastcancer.

Co-Chair,AccesstoCareworkinggroup.

2016-present

EditorinChiefJournalofClinicalOncology-ClinicalCancerInformatics

Developalookandfeelforthenewjournal

Assembleaneditorialboardandagroupofassociateeditorswith

complimentaryinformaticsexpertise.

Developrelationshipswithexternalstakeholderorganizationstobuildthe

brand.

2007-2018

MedicalDirector,BreastCancerSetonFamilyofHospitals

Drivegrowthandqualityofbreasthealthservicesthroughthenetworkby

benchmarkingoperationalandqualitymetrics.

Designandlaunchabreastcenter,andplanfornationalaccreditation.

Leadmultidisciplinarytumorboardsforbreastcancer.

Leadqualityimprovementprojectsforbreastcancerforthenetworkand

reporttothecancercommittee.

2008-2015

MedicalDirector,HealthcareInformaticsandHEORTheUSOncologyNetworkandMckessonSpecialtyHealth

Businessdevelopmentfrom2studiesatatimeto22studiesatatime.

Grewteamofanalystsandbusinessdevelopmentlead.

Developedaninternalchartreviewprocess.

Developedstreamlinedprocessworkflowandqualityimprovementprocesses.

IncreasedbrandawarenessofTheNetworkthroughmultiplepresentations

andpublications.

2006-2007

AdjunctProfessorMDAndersonCancerCenter,DivisionofCancerMedicine

AdministeredYoungInvestigatorsAwardGranttoconducthealthservices

researchinelderlypatientswithbreastcancertoevaluatelongtermtoxicities

associatedwithtreatment.

Education

2012-2014

TheUniversityofTexasatAustin,MccombsSchoolofBusiness,MastersinBusinessAdministration

2012-present

TheUniversityofTexasSchoolofPublicHealthABD

PhDPrograminHealthEconomicsandHealthServicesResearch

AnticipatedcompletionDecember,2018

Researchon"Evaluatingtheimpactonclinicaldecisionsupportsystemsto

nudgecompliancewithevidencebasedpathwaysinpatientswithcancerby

usingmixedeffectsmodels."

2000-2006

TheUniversityofTexasSchoolofPublicHealth,MastersinPublicHealthManagementandPolicySciences

2003-2006

MDAndersonCancerCenterFellowshipinHematologyandMedicalOncology

2005-2005

NationalCancerInstituteSummerFellowshipPrograminCancerPrevention

1999-2003

BaylorCollegeofMedicineResidencyinInternalMedicineandPediatrics

1995-1999

BaylorCollegeofMedicineDoctorateofMedicine

1992-1995

TheUniversityofTexasatAustin,ZoologyPlanIHonorsProgram,BS

ActiveResearch

2017 ImplementationofadvancedMRIinthecommunitysettingforpredictingthe

responseofbreastcancertoneoadjuvanttherapy.LeadPI:DrThomas

Yankeelov,SitePI:DrDebraPatt

2018 ProjectLONESTARevaluatingelectronicpatientreportedoutcomesin

communitypractice.COPIs:Dr.EthanBaschandDr.DebraPatt

2018 Modelingpredictiveanalyticstoevaluateriskof30dayhospitalizationin

patientswithadvancedcancer.

2015 Utilizingclinicaldecisionsupportsystemswithintheelectronichealthrecord

tofacilitatecompliancewithevidencebasedpathwaysforcancercare.

2018 UsingclinicalpharmacistinitiatedoralantiemeticprotocolstocontrolCINV

andenhancevalueincancercare.

LeadershipDevelopment

2013-2014

ASCOLeadershipDevelopmentProgramASCOHQ,Alexandria,VA

Ayearlongprogramofyoungnationalleadersinoncologywherewelearned

leadershipdevelopmentandpartnershipwithstakeholders.

2013 McKessonSpecialtyHealthTier2LeadershipDevelopmentProgram

2014-2016

McKessonSpecialtyHealthTier3LeadershipDevelopmentProgramLaunchedTelehealthpilotinTexasOncology

2015 TexasOncologyLeadershipDevelopmentProgram

Awards

2018SubmittedasCo-PrincipalInvestigator,NCIgranttoutilizeelectronic

patientreportedoutcomesinstrumentswithinastatewideoncologypractice

(SubmittedwithDr.EthanBasch,UNC)

2018SubmittedasCo-PrincipalInvestigator,NCIgranttousedynamicMRIto

evaluateearlyresponsetochemotherapyinlocalizedbreastcancer

(SubmittedwithDr.TomYankeelov,UTAustin)

2014RuthBainesYoungPhysicianoftheYearAward,TravisCountyMedical

Society

2006AmericanSocietyofClinicalOncologyYoungInvestigatorsAward

2006ResearchFellowoftheyear,MDAndersonCancerCenter

2006AmericanSocietyofClinicalOncologyMeritAward

2006JesseJonesFellowshipinCancerEducationandPreventionatMD

AndersonCancerCenter-theannualeducationandpreventionawardgiven

toonefellowwhohasdemonstratedexcellenceintheseareas.

Certificates

2003 TexasStateMedicalLicense

2003 AmericanBoardofInternalMedicine

2006 AmericanBoardofInternalMedicine,OncologySpecialtyExam

2017 AmericanBoardofInternalMedicineOncologySpecialtyExamRecertification

2007 AmericanBoardofInternalmedicine,HematologySpecialtyExam

BoardandCommitteeActivity

2017-present

ASCONominatingCommittee

2016-present

CommunityOncologyAllianceBoardofDirectors

2014-present

ASCOClinicalPracticeCommittee,Chair

2017-2017

ASCOEducationCommittee

2011-2016

PublicationsandOutcomesCommitteeChair,MSH

2011-present

USOncologyNationalPolicyBoard

2009-2015

TexasMedicalAssociationCancerCommittee,Chair

2015-2016

TexasMedicalAssociationCommitteeonScienceandPublicHealth

2016-present

TexasMedicalAssociation,CouncilonLegislation

2017-present

ASCOEHR,technology,anddataworkinggroup

2015-2017

KomenAustinBoardofDirectors

2011-2014

BreastCancerResourceCenterBoardofDirectors

2006-present

AdvisoryCounciloftheTexasCancerRegistry

2008-present

PharmacyandTherapeuticsCommittee,USON

2011-present

CollaborativeCareCommittee,MSH

2011-2017

PatientPortalandOncologyPortalWorkingGroup,MSH

2017-present

COAGovernmentRelationsCommittee

2017-present

COAPaymentReformCommittee

2014-present

ASCOPaymentReformandPolicyCommittee

Publications

PattD."DebraPattonHowtheManagementofCancerisChangingas

PatientsLiveLonger."Oncology(WillistonPark).2018Jun15

RamakrishnaN,TeminS,ChandarlapatyS,CrewsJR,DavidsonNE,Esteva

FJ,GiordanoSH,KirshnerJJ,KropIE,LevinsonJ,ModiS,PattDA,

PerlmutterJ,WinerEP,LinNU."RecommendationsonDiseaseManagement

forPatientsWithAdvancedHumanEpidermalGrowthFactorReceptor2-

PositiveBreastCancerandBrainMetastases:ASCOClinicalPractice

GuidelineUpdate."JClinOncol.2018Jun25

GiordanoSH,TeminS,ChandarlapatyS,CrewsJR,EstevaFJ,KirshnerJJ,

KropIE,LevinsonJ,LinNU,ModiS,PattDA,PerlmutterJ,RamakrishnaN,

WinerEP,DavidsonNE."SystemicTherapyforPatientsWithAdvanced

HumanEpidermalGrowthFactorReceptor2-PositiveBreastCancer:ASCO

ClinicalPracticeGuidelineUpdate."JClinOncol.2018Jun

25:JCO201879269

DenduluriN,LymanGH,WangY,MorrowPK,BarronR,PattD,BhowmikD,

LiX,BhorM,FoxP,DhandaR,SaravananS,JiaoX,GarciaJ,CrawfordJ.

“ChemotherapyDoseIntensityandOverallSurvivalAmongPatientsWith

AdvancedBreastorOvarianCancer.”ClinBreastCancer.2018

SoraceAG,WuC,BarnesSL,JarrettAM,AveryS,PattD,GoodgameB,

LuciJJ,KangH,AbramsonRG,YankeelovTE,VirostkoJ.“Repeatability,

reproducibility,andaccuracyofquantitativemriofthebreastinthecommunity

radiologysetting.”JMagnResonImaging.2018

PattD,PageR.“MeasuringQualityIsComplicated.”JOncolPract.2017

VirostkoJ,HainlineA,KangH,ArlinghausLR,AbramsonRG,BarnesSL,

BlumeJD,AveryS,PattD,GoodgameB,YankeelovTE,SoraceAG.

“Dynamiccontrast-enhancedmagneticresonanceimaginganddiffusion-

weightedmagneticresonanceimagingforpredictingtheresponseoflocally

advancedbreastcancertoneoadjuvanttherapy:ameta-analysis.”JMed

Imaging(Bellingham).2018

PattDA“Utilizationmanagementinoncology”JClinOncol.2017;35(suppl

8S;abstract172).

CookeKJ,PattDA,PrabhuRS.“TheRoadofMentorship.”AmSocClin

OncolEducBook.2017;37:788-792.

PattDA,BernstamEV,MandelJC,KredaDA,WarnerJL.“MoreMedicine,

FewerClicks:HowInformaticsCanActuallyHelpYourPractice.”AmSocClin

OncolEducBook.2017;37:450-459

RobertNJ,GoertzHP,ChopraP,JiaoX,PattD,AntaoV“Her2-positive

metastaticbreastcancerpatientsreceivingpertuzumabinacommunity

oncologypracticesetting:Treatmentpatternsandoutcomes”DrugsReal

WorldOutcomes2017

AgiroA,MaQ,AchesonAK,WuSJ,PattDA,BaronJJ,MalinJ,SchilskyRL,

LymanGH“RiskofNeutropenia-RelatedHospitalizationinPatientsWho

ReceivedColony-StimulatingFactorswithChemotherapyforBreastCancer”

JClinOncol2016

PattD“BetterScreeningUsingBigData”JOncolPract2016Aug;12(8):699-

700

LiangC,LiL,FraserCD,KoA,CorzoD,EngerC,PattD“Thetreatment

patterns,efficacy,andsafetyofnab-paclitaxelforthetreatmentofmetastatic

breastcancerintheUnitedStates:resultsfromhealthinsuranceclaims

analysis”BMCCancer2015

DenduluriN,PattDA,WangY,BhorM,LiX,FavretAM,MorrowPK,Barron

RL,AsmarL,SaravananS,LiY,GarciaJ,LymanGH.DoseDelays,Dose

Reductions,andRelativeDoseIntensityinPatientsWithCancerWho

ReceivedAdjuvantorNeoadjuvantChemotherapyinCommunityOncology

Practices.JNatlComprCancNetw.2015

YasenchakCA,TsengWY,YapM,RembertD,PattDA.“Economicimpactof

diseaseprogressionfollowingfront-linetherapyinclassicalHodgkin

lymphoma.”LeukLymphoma2015

SchadendorfD,HodiFS,RobertC,WeberJS,MargolinK,HamidO,PattD,

ChenTT,BermanDM,WolchokJD.“PooledAnalysisofLong-TermSurvival

DataFromPhaseIIandPhaseIIITrialsofIpilimumabinUnresectableor

MetastaticMelanoma”JClinOncol2015

RamakrishnaN,TeminS,ChandarlapatyS,CrewsJR,DavidsonNE,Esteva

FJ,GiordanoSH,Gonzalez-AnguloAM,KirshnerJJ,KropI,LevinsonJ,Modi

S,PattDA,PerezEA,PerlmutterJ,WinerEP,LinNU.“Recommendationson

DiseaseManagementforPatientsWithAdvancedHumanEpidermalGrowth

FactorReceptor2-PositiveBreastCancerandBrainMetastases:American

SocietyofClinicalOncologyClinicalPracticeGuideline.“JClinOncol.2014

GiordanoSH,TeminS,KirshnerJJ,ChandarlapatyS,CrewsJR,Davidson

NE,EstevaFJ,Gonzalez-AnguloAM,KropI,LevinsonJ,LinNU,ModiS,

PattDA,PerezEA,PerlmutterJ,RamakrishnaN,WinerEP.“Systemic

TherapyforPatientsWithAdvancedHumanEpidermalGrowthFactor

Receptor2-PositiveBreastCancer:AmericanSocietyofClinicalOncology

ClinicalPracticeGuideline.”JClinOncol.2014

PattDA“Takingonracialandethnicdisparitiesincancercare”JCommunity

andSupportiveOncology2014

Reeder-HayesK,FelipE,PattD,JaffeeE.“Womeninoncology”AmSocClin

OncolEduc.Book2013;448-55.2013

RamseySD,SullivanSD,ReedSD,TinaShihYC,SchaecherK,DhandaR,

PattD,PendergrassK,WalkerM,MalinJ,SchwartzbergL,NeumannK,Yu

E,RaveloA,SmallA.“Oncologycomparativeeffectivenessresearch:a

multistakeholderperspectiveonprinciplesforconductandreporting.”

Oncologist2013;18(6):760-7.EpubMay6,2013

BrowM,OkonT,GeorgeE,EagleD,PattD,GouldB,BrooksB,CobbP,

WhiteC,TetraultS,BeveridgeR.“Thoughtsandrecommendationsoncancer

caresiteofservice”CommunityOncology20129(2)pages382-385.

BrowM,HovermanJR,PattD,HermanB,VerrilliD,GareyJ,BeveridgeR.

“Definingcancercarequalityordeliveringqualitycancercare?”JNatlCompr

CancNetw.2013Feb1;11(2):121-4.

Chen,C,Dhanda,R,Tseng,W,Forsyth,M,Patt,D.“EvaluatingUse

CharacteristicsfortheOncotypeDX21-generecurrencescoreand

concordancewithchemotherapyuseinearlystagebreastcancer”JOncol

PractFeb2013

KolodziejM,HovermanJR,GareyJS,EspiritoJ,ShethS,GinsburgA,

NeubauerMA,PattD,BrooksB,WhiteC,SitarikM,AndersonR,Beveridge

R.“Benchmarksforvalueincancercare:ananalysisofalargecommercial

population.”JOncolPract.2011

PattD,EspiritoJ,TurnwaldB,HovermanJ,NeubauerM,CartwrightT,Busby

L,BrooksB,SitarikM,KolodiejM,BeveridgeR.”Changesinadjuvantbreast

cancerchemotherapyregimenselectionovertimeinthecommunity”May30,

2012:6109.PublishedinJCOsupplements

PattD,EspiritoJ,TurnwaldB,HovermanJ,NeubauerM,BusbyL,Brooks,

Kolodziej,AndersonR,BeveridgeR“Utilizationofpegfilgrastiminadjuvant

chemotherapyregimensforbreastcancerinthecommunity”Sep30,

2011:213PublishedinJCOsupplements

ChenC,PattD,KazzazD,ShankletonJ,ForsythM,GaneshR.“Evaluating

utilizationcharacteristicsfortheOncotypeDXrecurrencescoreinearly-stage

breastcancer”Jun9,2011:625.PublishedinJCOsupplements

GinsburgA,PattD,FlinnJ,EspiritoJ,NeubauerM,CartwrightT,Hoverman

J,BusbyB,Brooks,BKolodziejM,SitarikM,AndersonR,BeveridgeR.

“Understandingmalebreastcancerinthecommunitysetting”ASCO

MEETINGABSTRACTSJun9,2011:e16526PublishedinJCOsupplements

PattD,EspiritoJ,TurnwaldB,HovermanJ,NeubauerM,CartwrightT,

BrooksB,BusbyL,SitarikM,KolodziejM,GinsburgA,ShethS,GareyJ,

ClaytonM,NelsonR,AndersonR,BeveridgeR.“Utilizationandrelativevalue

ofbreastcanceradjuvantchemotherapyregimensinthecommunity”Jun9,

2011:e16595.PublishedinJCOsupplements

Hoverman,JR.CartwrightTH.Patt,DA.Espirito,JL.Clayton,MP.Garey,JS.

Kopp,TJ.Kolodziej,M.Neubauer,M.Fitch,K.Pyenson,B.Beveridge,RA.

“Pathways,Outcomes,andCostsinColonCancer:Retrospectiveevaluations

intwodistinctdatabases”JournalofOncologyPracticeMay2011.

O’Shaughnessy,J.Osborne,C.Pippen,JE.Yoffee,M.Patt,D.RochaC.Koo,

IC.ShermanBM.Bradley,C.“IniparibplusChemotherapynMetastaticTriple-

NegativeBreastCancer”NEJM2011Jan20;364(3):205-14.Epub2011Jan

5

Socinski,MA.Raju,RN.Stinchombe,T.Kocs,DM.Couch,LS.Barrera,D.

Rousey,SR.Choksi,JK.Jotte,R.Patt,DA.Periman,PO.Schlossberg,HR.

Weissman,CH.Wang,Y.Asmar,L.Pritchard,S.BromundJ.Peng,G.Treat,

J.Obasaju,CK.“RandomizedphaseIItrialofpemetrexedandcarboplatin

withorwithoutenzastaurinversusdocetaxelandcarboplatinasfirst-line

treatmentofpatientswithstageIIIB/IVnon-smallcelllungcancer”JThorac

Oncol2010

Scholl,P.Snyder,N.Patt,D.Talbott,B.“Pilomatricalcarcinosarcoma”

Otolaryngology-HeadandNeckSurgery2010143,s36-37.

Patt,D,Espirito,J,Turnwald,B,Hoang,S,Hoverman,J.“Ixabepilonealone

andincombinationwithchemotherapyinthecommunitysetting”Proceedings

ASCOBreastCancerSymposium.Abstract204.2010.

Neubauer,MA.Espirito,JL,Clayton,M.Patt,DA.“Combinationversus

sequentialchemotherapyformetastaticbreastcancer:Anevaluationof

outcomesfromacommunityoncologynetwork”JCO28:15s,2010(suppl;

abstr6106).

PattD,ZhigangD,ShenyingF,HortobagyiG,GiordanoS.“AcuteMyeloid

LeukemiaafterAdjuvantBreastCancerTherapyinOlderWomen:

UnderstandingRisk”JCO2007September125(25)3871-6.

Patt,DebraandGiordano,SharonH.“PaclitaxelinBreastCancer”Women’s

HealthJanuary2006Jan.2:1(11)11-21

Patt,D,GoodwinJ,Kuo,Y,FreemanJ,ZhangD,BuccholzT,HortobagyiG,

GiordanoS.“Cardiacmorbidityofadjuvantradiotherapyinpatientswithearly

stagebreastcancer”JCO2005.October20.23(30)7475-82.

PattD,ShoplandD,AndersonC,BurnsD,DunningtonJ,GritzE.“Trendsto

protectworkersfromjobrelatedsecondhandsmokeinTexas”Texas

Medicine.2005Dec;101(12):50-6.